A FormBlends network publication

NovoCare Pharmacy: evaluation

Novo Nordisk's self-pay direct-to-patient pharmacy for Wegovy and Ozempic scored on the FormBlends Reviews rubric from public pages on 2026-09-04: a fully identified pharmacy, per-dose prices with dated introductory offers, bring-your-own-prescription, free delivery, and no refund policy findable. 16 of 24.

By FormBlends editorial teamUpdated September 4, 2026Educational, not medical advice

What NovoCare Pharmacy offers

A self-pay, direct-to-patient pharmacy offer for Wegovy and Ozempic, per fill, with no membership. The pharmacy is fully identified: CoAssist Pharmacy d/b/a NovoCare Pharmacy (2400 Sand Lake Road, Suite 200B, Orlando, FL 32809; NPI 1710671854; NCPDP 5758074) handles intake, with CenterWell Pharmacy handling accounts, payment, fulfilment and shipping and AssistRx providing patient support. Novo Nordisk does not provide telehealth; a find-a-doctor page lists independent options (9amHealth, eMed, FormHealth, KnownWell, LifeMD, Ro, Sesame, WeightWatchers) with a statement that Novo does not endorse or compensate them.

Medications: brand or compounded

Brand Wegovy (pen and pill) and Ozempic (pen and pill) only. FDA approved. Nothing compounded.

Price as published (2026-09-04)

Wegovy pen: $199 a month for the 0.25 mg and 0.5 mg doses for new patients, two monthly fills through December 31, 2026, then $349 a month for 0.25 to 2.4 mg and $399 a month for the 7.2 mg dose. Wegovy pill: 1.5 mg $149; 4 mg $199 (a limited-time $149 tablet offer is shown as expiring August 31, 2026); 9 mg and 25 mg $299 a month. Ozempic pen: $199 a month for 0.25 and 0.5 mg (two fills through December 31, 2026), then $349 a month for 0.25 to 1 mg and $499 a month for 2 mg. Ozempic pill: $149 to $299 a month by dose. One month is one box of four pens or 30 tablets. Free home delivery. A 90-day supply is available on request. Cannot be combined with other offers or reimbursed by insurance. Prescriber visits and labs are outside the program and not priced.

Prescriber model

You obtain a prescription from any licensed provider. Novo lists independent telehealth options without stating their fees or visit models. The prescriber model you get is the partner's, and the prescriber licence guide applies to that partner.

Pharmacy sourcing statements

CoAssist Pharmacy is described as licensed in all 50 states and US territories, with NPI and NCPDP numbers published. No LegitScript or NABP badge was found, but the identifiers make a state board lookup straightforward.

Refund terms as published

No refund, return or cancellation policy was found on any pharmacy page read; the pharmacy FAQ URL returned an error to our tools. The offer pages say Novo reserves the right to modify or cancel the program at any time. A phone number for damaged shipments is given (1-800-967-9917). Ask the pharmacy for its policy before ordering.

Support and privacy

Phone 1-888-809-3942, Monday to Friday 8 am to 8 pm Eastern; a prescriber line Monday to Friday 9 am to 5 pm Eastern; CoAssist offers a phone line and live chat through the AssistRx site. No response times stated. The Novo Nordisk Inc. privacy notice (January 2025) governs the pages: no HIPAA statement, permission to share with affiliates, vendors and third parties, and a "Your Privacy Choices" opt-out. A pharmacy-specific notice of privacy practices was not found.

Regulatory record, primary documents only

  • FDA warning letter to Novo Nordisk Inc., March 5, 2026: inadequate procedures for 15-day adverse event reporting.
  • FDA warning letter to Novo Nordisk Inc., September 9, 2025: a promotional video on Wegovy, Ozempic and Victoza omitted and minimised risks.
  • FTC warning letter to Novo Nordisk Inc., April 30, 2024: the FTC challenged patent listings for Ozempic, Saxenda and Victoza in the FDA's Orange Book.
  • The FDA's March 3, 2026 press release about compounded GLP-1 marketing names no recipients.

These concern the manufacturer, not the pharmacy channel, and none moves a score.

Scores

NovoCare Pharmacy on the FormBlends Reviews rubric v1.0, public pages read 2026-09-04
CriterionScoreWhy
Licensure and state coverage3 of 3Pharmacy named with address, NPI and NCPDP, licensed in all 50 states and territories; no medical group because Novo does not prescribe.
Prescriber model1 of 3Bring your own prescription; independent options listed without endorsement or detail.
Pharmacy sourcing transparency3 of 3Brand only, named pharmacy, named fulfilment partner.
Pricing transparency3 of 3Price per dose, dated introductory offers with the price that follows, one month defined, free delivery stated.
Refund and cancellation terms0 of 3No policy found; only a damaged-shipment phone line.
Medication supply chain and COA availability3 of 3Brand only; Novo Nordisk is the manufacturer.
Support access2 of 3Phone with hours, a prescriber line and live chat; no response time or urgent route.
Privacy1 of 3Corporate notice without a HIPAA statement; pharmacy notice of privacy practices not found.

Total: 16 of 24.

What to ask them

  1. What is the pharmacy's refund policy if a shipment is damaged, lost or delivered warm, and what is the reporting window?
  2. Does the $199 introductory price apply to me, and exactly when does it step up to $349?
  3. Can I set up or stop auto-refill, and how?
  4. Where is the notice of privacy practices for CoAssist Pharmacy?
  5. Which of the listed telehealth options covers my state, and what do they charge?

Compare on the same rows in the comparison builder.

Change log

  • 2026-09-04: first publication, rubric v1.0.

Canonical URL: https://formblendsreviews.com/evaluations/novocare-pharmacy. Written by the FormBlends editorial team. This page is educational and is not medical advice; see the medical disclaimer.